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Previous plant–based vaccine for   
animal rabies: 
Production system Maximum accumulation level  
Tomato leaves and fruit 0.001% TSP 
Tobacco leaves 0.38% TSP 
Cantaloupe melon fruits 1.2% TSP 
Carrots 1.2% TSP 
Maize 1% TSP 
Advantages 
Cost efficiency. 
No need for “cold chain”. 
Eliminate cost of syringes and needles. 
Reduced need of medical assistance in administration. 
Oral application. 
Ideal for veterinary use. 
Mucosal and serum immune response. 
Reduced concerns due to the non use of pathogens  
Disadvantages 
Low levels of protein expression (~1% TSP). 
Need of high levels of proteins in animals. 
Protein degradation in intestinal tract. 
Need for protein purification. 
 
Development of a cheap and efficient vaccine using a plant 
expression system against MOKV by oral immunization. 
 
•     To obtain a transgenic plant which contains the G glycoprotein of MOKV.      
•     To observe normal growth and phenotype in the genetically modified plant. 
•     To find the optimal dosage for the immunization in mice. 
•     To maximize the accumulation of G protein >1% of TSP. 
•     To achieve a significant difference in the survival between mice immunized with  the 
plant based-vaccine and mice immunized with Rabipur. 
General objective 
Objectives Specific objectives 
Expected results 
• pCAMBIA380MOKV would be obtained successfully. 
• The G gene would be detected by PCR in the transformed plants. 
• The G protein would be identified and quantified. 
• To observe a clear difference in health and behavior between the mice immunized with transformed maize and mice immunized with Rabipur.  
• The plant expression system would present significant difference (p < 0.05) in survival compared with Rabipur. 
• Both mice groups orally immunized with 1g and 3g of G protein would be protected against MOKV. 
 
 
Rosales-Mendoza S. et al., (2012) Vaccine 31; 40-48.              Rojas E. (2009) Transgenic Research 18; 911-919.                Sreatfield S.J. (2005) Rev. sci. tech. Off. Int. Epiz. 24 (1); 189-199. 
Oneto et al., (2011) African Journal of Agricultural Research Vol. 5(25); 3561-3570.            Lee L. et al., (2008) Plant Physiol. 146; 325–332.                      Loza E. et al., (2008) Dev Bioi. Basel, Karger Vol. 131; 477-487.  
Bibliography 
Statistical analysis 
•  1st group: 1g of G protein / mice. 
•  2nd group: 3g of G protein / mice. 
•  3rd group: Rabipur. 
•  Control group: wt maize kernels 
PCR analysis 
Western blot analysis 
Quantification on G protein by densitometry 
Immunization o Balb/c mice 
Transformation by binary vector systems 
Agrobacterium tumefaciens. Strain LBA4404 
Co-cultivation for 3d 
Maize ( Zea mays) 
 Line Hi-II 
Co-cultivation with 
Agrobacterium 
T-DNA binary 
vector 
vir 
helper 
Regeneration for 14d 
Medium with Basta 
Growth in a 
greenhouse 
Co-cultivation for 5d 
Medium without herbicide 
Transfer to  
selective medium 
1st selection for 14 days 
2nd selection for 21 days 
3rd selection for 21 days 
Rooting medium 
Material and methods 
Introduction of 
pCAMBIA0380MOKV  
by electroporation 
Family: Rhabdoviridae 
Genus: Lyssavirus (genotype 3) 
Mokola virus (MOKV) 
• Exclusively found in Africa. 
• Never isolated in bats. 
• Reported cases since 1968. 
• Genetically the most distant from rabies virus. 
MOKV  structural organization: 
Rabies virus vaccination fail to protect against MOKV. 
Introduction 
Rabies 
Plant-based vaccines 
Zoonotic disease which causes 55.000 annual deaths in humans worldwide. 
Lane 1: MW. 
Lane 2: Mokola virus. 
Lane 3: Wt plant. 
Lanes 4–6: Transformed plants.  
Lanes 1–3: Transformed plants. 
Lanes 4 / 5: negative /  positive control.  
